- Home
- CNM vs SNN Comparison
CNM vs SNN Comparison
Compare CNM & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNM
- SNN
- Stock Information
- Founded
- CNM 1996
- SNN 1856
- Country
- CNM United States
- SNN United Kingdom
- Employees
- CNM 5700
- SNN N/A
- Industry
- CNM Durable Goods
- SNN Industrial Specialties
- Sector
- CNM Consumer Discretionary
- SNN Health Care
- Exchange
- CNM Nasdaq
- SNN Nasdaq
- Market Cap
- CNM 9.0B
- SNN 15.2B
- IPO Year
- CNM 2021
- SNN 1999
- Fundamental
- Price
- CNM $47.21
- SNN $32.78
- Analyst Decision
- CNM Buy
- SNN Hold
- Analyst Count
- CNM 11
- SNN 4
- Target Price
- CNM $60.64
- SNN $32.83
- AVG Volume (30 Days)
- CNM 1.9M
- SNN 613.9K
- Earning Date
- CNM 12-02-2025
- SNN 10-30-2025
- Dividend Yield
- CNM N/A
- SNN 2.24%
- EPS Growth
- CNM 7.24
- SNN 59.91
- EPS
- CNM 2.25
- SNN 0.56
- Revenue
- CNM $7,740,000,000.00
- SNN $5,944,000,000.00
- Revenue This Year
- CNM $4.45
- SNN $7.85
- Revenue Next Year
- CNM $4.43
- SNN $5.43
- P/E Ratio
- CNM $20.98
- SNN $28.37
- Revenue Growth
- CNM 11.02
- SNN 5.35
- 52 Week Low
- CNM $41.64
- SNN $23.69
- 52 Week High
- CNM $67.18
- SNN $38.79
- Technical
- Relative Strength Index (RSI)
- CNM 27.31
- SNN 32.54
- Support Level
- CNM $49.97
- SNN $33.05
- Resistance Level
- CNM $51.56
- SNN $33.66
- Average True Range (ATR)
- CNM 1.40
- SNN 0.49
- MACD
- CNM -0.39
- SNN -0.34
- Stochastic Oscillator
- CNM 6.74
- SNN 17.80
About CNM Core & Main Inc.
Core & Main is a leading specialty distributor with a focus on water, wastewater, storm drainage, and fire protection products. The company provides solutions to municipalities, private water companies, and professional contractors across municipal, nonresidential, and residential end markets. The company's specialty products and services are used in the maintenance, repair, replacement, and construction of water and fire protection infrastructure.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.